Research priorities - Faculty of Pharmaceutical, Biomedical and Veterinary Sciences
Research priorities
In 2010 the University of Antwerp defined nine research priorities, drawing together the areas of both fundamental and applied research in which the University of Antwerp has built up long-standing expertise and an international reputation for excellence. These priorities help determine research funding needs and identify partnerships in industry. In addition to the nine research priorities there are also three growth points, which may be future priorities.
The Faculty of Pharmaceutical, Biomedical and Veterinary Sciences conducts research in five of these nine priority fields and in two of the three growth points:
Priority: Drug Research
A large portion of the research carried out in these fields is covered by the Antwerp Drug Discovery Network (ADDN), which the World Health Organization (WHO) recognises as a Reference Centre.
Faculty research groups involved
Bio-Imaging Lab
Physiopharmacology
Galenic and Industrial Pharmacy and Biopharmacy
Laboratory for Microbiology, Parasitology and Hygiene (LMPH)
Laboratory for Pharmacognosy, Functional Food and Pharmaceutical Analysis
Medicinal Chemistry
Medical Biochemistry
Pathophysiology
Priority: Neurosciences
However, the research carried out in this priority area extends even further than the research done at NEURO. Several well-equipped laboratories are conducting both fundamental and applied research into complementary or related research areas, such as neuroplasticity and cognitive and behavioural neurosciences.
The University of Antwerp's extensive expertise in neurosciences is also reflected in its educational programmes: The Faculty of Pharmaceutical, Biomedical and Veterinary Sciences offers students the chance to specialise in Neurosciences as part of the Biomedical Sciences programme.
Involved research clusters from the Faculty of Pharmaceutical, Biomedical and Veterinary Sciences
Bio-Imaging Lab
Cell Biology and Histology
Medical Genetics cluster
VIB - Department of Molecular Genetics cluster
Laboratory of Molecular Biophysics, Physiology and Pharmacology
Laboratory for Theoretical Neurobiology and Neuroengineering
Neurochemistry and Behaviour
Core Facilities involved
Antwerp Biobank
Genetic Service Facility
Biomedical Microscopic Imaging
Bio-Imaging Lab
Priority: Imaging
Expertise in this field is grouped under the ‘Expert Group Antwerp Molecular Imaging’ (EGAMI). Also involved in this interfaculty group are the Cell Biology and Histology group's Biomedical Microscopic Imaging core facility as well as the Bio-Imaging Lab, Molecular Imaging Center Antwerp (MICA) and the Vision Lab.
Strong links have also been established with research conducted at Antwerp University Hospital (UZA) on radiology and nuclear medicine. The highlight of this collaboration was the opening of the Molecular Imaging Center Antwerp (MICA) in the spring of 2011, a partnership between the University of Antwerp, UZA and Janssen Pharmaceutica.
Faculty research groups involved
Bio-Imaging Lab
Cell Biology and Histology (CH)
Core Facilities involved
Biomedical Microscopic Imaging
Bio-Imaging Lab
Priority: Infectious Diseases
Faculty research groups involved
Laboratory for Microbiology, Parasitology, and Hygiene (LMPH)
Priority: Ecology and Sustainable Development
One of the research topics addressed in this field is environmental toxicology. Our faculty's years of research in this area have led to a better understanding of the impact that toxic substances have on the biological organisation and complexity of the environment. We make use of a wide range of testing methods in order to measure and characterise environmental impact, from the molecule right up to the ecosystem as a whole.
Faculty research group involved
Toxicology
Growth point: Genomics and Proteomics
Faculty research groups involved
Medical Genetics
Protein chemistry, proteome analysis and epigenetic signalling (PPES)
Medical Biochemistry
Growth point: Oncology
xyz